In Staphylococcus aureus, penicillin-binding protein 2 (PBP 2) has been implicated in non-PBP 2a-mediated methicillin resistance. The PBP 2 gene (pbpB) was cloned from an expression library of a methicillin-susceptible strain of S. aureus (209P), and its entire sequence was compared with that of the pbpB gene from strains BB255, BB255R, and CDC6. Point mutations that resulted in amino acid substitutions near the conserved penicillin-binding motifs were detected in BB255R and CDC6, two low-level methicillin-resistant strains. Penicillin binding to PBP 2 in both BB255R and CDC6 is altered, and kinetic analysis indicated that altered binding of PBP 2 by penicillin was due to both lower binding affinity and more rapid release of bound drug. These structural and biochemical changes may contribute to the strains' resistance to -lactam antibiotics.Penicillin-binding proteins (PBPs) catalyze the cross-linking of the peptidoglycan subunits in the bacterial cell wall, and their transpeptidase activity is essential for the cell's structural integrity (31). With -lactamases, PBPs form a superfamily of penicillin-interacting serine D,D-peptidases. These enzymes have a lysine residue downstream from the active site serine that is required for their catalytic activity (14). This S-X-X-K sequence is a conserved motif in the transpeptidase domain of this class of enzymes. S-X-N and K(H)-T(S)-G sequences downstream of the active site serine are also conserved and are instrumental to the penicillin-binding reaction. -Lactam antibiotics are structural analogs of the PBP substrate, and their mechanism of action involves covalently binding the active site of the enzyme, thus preventing its function. The sensitivity of prokaryotes to these antibiotics is primarily due to their PBPs having a high affinity for the drugs.Seven PBPs have been identified in Escherichia coli, and most have been sequenced. The low-M r E. coli PBPs (no. 4, 5, and 6) appear to have carboxypeptidase, rather than transpeptidase, activity and to be nonessential for growth (29,31). The high-M r PBPs (1A, 1B, 2, and 3) are bifunctional enzymes with a penicillin-insensitive transglycosylase domain as well as a penicillin-sensitive transpeptidase domain (15-17). -Lactams exert their lethal effects by inactivating one or more of these high-M r PBPs.The genes from Streptococcus pneumoniae PBP 1A (21), Streptococcus oralis PBP 1A (21), and Bacillus subtilis PBP F (11, 25) were recently cloned, and the peptides from their translated nucleotide sequences are homologous to the transpeptidase domains of PBPs 1A and 1B from E. coli. Unlike the bifunctional enzymes in E. coli, these high-M r PBPs from gram-positive organisms do not appear to have transglycosylase activity.Four PBPs (no. 1 to 4) with M r s of 85, 81, 75, and 45, respectively, have been identified in susceptible strains of Staphylococcus aureus (8). In addition to PBPs no. 1 to 4, mecA-encoded PBP 2a is produced by methicillin-resistant staphylococci, and its production mediates most methicillin resistance ...